JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 12, 2004; DOI: 10.1124/jpet.104.071415


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.071415v1
311/3/1154    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Misra, S.
Right arrow Articles by Grider, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Misra, S.
Right arrow Articles by Grider, J. R.


Received for publication May 14, 2004.
Revised July 22, 2004.
Accepted for publication July 26, 2004.

Co-Expression of Y1, Y2 and Y4 Receptors in Smooth Muscle Coupled to Distinct Signaling Pathways

Sudhakar Misra 1, Karnam S. Murthy 1, Huiping Zhou 1, John R. Grider 1*

1 Virginia Commonwealth University

* Address correspondence to: E-mail: jgrider{at}hsc.vcu.edu

Abstract

Co-expression of Y1, Y2, and Y4 receptors on smooth muscle cells was determined by RT-PCR and the receptors were characterized by radioligand binding, selective receptor protection, and functional analysis of signaling pathways. 125I-PYY binding was completely inhibited by NPY and PYY, and partially inhibited by the Y1 agonist, [Leu31, Pro34]NPY or the Y2 agonist, NPY13-36. In cells where Y1 receptors were preserved by selective receptor protection, 125I-PYY binding was selectively inhibited by the selective Y1 agonist or antagonist (BIBP 3226). Conversely, in cells where Y2 receptors were preserved, 125I-PYY binding was selectively inhibited by the Y2 agonist or antagonist (BIIE 0246). All Y receptors activated preferentially Gi2, but only Y2 and Y4 receptor activated Gq. Consequently, Y2 agonists (NPY, PYY, NPY13-36) and the Y4 agonist (PP) induced concentration-dependent contraction, IP3 formation and increase in [Ca2+]i. Contraction induced by Y2 and Y4 agonists was not affected by 0 Ca2+, Ca2+ channel blockers or PTx, but was abolished by thapsigargin, U73122, or the MLCK inhibitor, ML-9. Y2-mediated contraction was inhibited by the selective Y2 antagonist, BIIE 0246. Insensitivity to PTx implied that the coupling to Gi did not initiate (Y1) or contribute (Y2 and Y4) to contraction. All Y receptor agonists inhibited cAMP formation in a PTx-sensitive fashion. The patterns of contraction and inhibition of cAMP by various Y receptors were corroborated by selective receptor protection. The study demonstrates co-expression of Y1, Y2, and Y4 receptors on smooth muscle negatively coupled to adenylyl cyclase via Gi2. Coupling of Y2 and Y4 receptors to Gq determines their ability to induce IP3-dependent Ca2+ release and contraction.


Key words: Contraction, G proteins, Receptors, Signal transduction, cAMP, smooth muscle


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Hu, S. Mahavadi, F. Li, and K. S. Murthy
Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1991 - C2000.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. Hu, S. Mahavadi, J. Huang, F. Li, and K. S. Murthy
Characterization of S1P1 and S1P2 receptor function in smooth muscle by receptor silencing and receptor protection
Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G605 - G610.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.